Med 7 llc, announce the completion of a safety and efficacy study using hempzorb81™ full spectrum oil in patients with type ii diabetes
BLUFFDALE, Utah, April 29, 2021 /CNW/ — Med7, LLC (www.Med7cbd.com) and HempCo, Inc. announce the completion of a human clinical study in patients with Type II Diabetes using Purzorb® technology, now trademarked as Hempzorb81TM. “This study will provide our customers and providers with evidence based products not seen to this point in the Industrial Hemp and CBD market place,” […]